What Is The Current and Historic Market Size Analysis Of The Cell Dissociation Market?
The cell dissociation market has seen considerable growth due to a variety of factors.
• In the past few years, the market size for cell dissociation has seen a fast-paced expansion. The market, previously valued at $0.38 billion in 2024, is projected to reach $0.43 billion in 2025, with a compound annual growth rate (CAGR) of 13.0%.
This growth during the historical period can be credited to several factors including an increase in diabetes, the surge in infectious diseases, the rise in animal-based components, expanding regenerative medicine, and escalating cancer cases.
What Is The Forecast For The Cell Dissociation Market Size?
The cell dissociation market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for cell dissociation is set to experience accelerated growth in the forthcoming years, expanding to $0.69 billion by 2029 with an annual compounded growth rate (CAGR) of 12.7%.
The projected growth during this forecast period is due to various factors such as the increasing endorsement of cell-based research, a rise in clinical trials, expansion of biopharmaceutical and pharmaceutical companies, a growing incidence of chronic illnesses, and a rise in neurological disorders. The forecast period will also see key trends such as the progression in patient-specific cell therapies, technological advancements, launching of fingerprint-based drug screenings, the initiation of enzymatic cell dissociation techniques, and the creation of monoclonal antibodies.
What Are The Essential Drivers Behind The Growth Of The Cell Dissociation Market?
The rise in chronic diseases is set to boost the cell dissociation market's progress moving forward. This surge is attributed to factors including an aging populace, lifestyle alterations, and escalated obesity rates, inactive physical behavior, and unhealthy dietary habits that pave the way for sustained development and persistence of diseases such as diabetes, heart disease, and cancer. Cell dissociation remains crucial for the study of chronic diseases as it lets researchers segregate and study individual cells, facilitating a better understanding of disease mechanisms and the creation of targeted treatments. For example, in August 2022, the American College of Cardiology, a non-profit medical association operating in the US, published a report projecting that all four major cardiovascular risk factors will see rises from 2025 to 2060 in the US. Diabetes is predicted to witness the most significant percentage growth, that is, a 39.3% surge taking the total to 55 million people, followed by dyslipidemia (increasing by 27.6% to 126 million), hypertension (rising by 25.1% to 162 million), and obesity (amplifying by 18.3% to 126 million). Additionally, substantial rise is expected in the rates of cardiovascular diseases such as stroke (increase of 33.8% to 15 million) and heart failure (surge of 33.4% to 13 million), closely trailed by ischemic heart disease (growth of 30.7% to 29 million) and heart attack (an uptick of 16.9% to 16 million). Hence, the escalating frequency of chronic diseases fuels the expansion of the cell dissociation market.
How Is The Global Cell Dissociation Market Divided Into Key Segments?
The cell dissociationmarket covered in this report is segmented –
1) By Product: Enzymatic Dissociation, Non-enzymatic Dissociation, Instruments And Accessories
2) By Tissue: Epithelial Tissue, Connective Tissue
3) By Application: Tissue Dissociation, Cell Detachment
4) By End-User: Pharmaceuticals And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CRO), Other End-Users
Subsegments:
1) By Enzymatic Dissociation: Trypsin Solutions, Collagenase Solutions, Dispase Solutions, Other Enzymatic Dissociation Reagents
2) By Non-Enzymatic Dissociation: Chemical Dissociation Solutions, Mechanical Dissociation Solutions, Hypotonic Solutions
3) By Instruments and Accessories: Cell Dissociation Systems, Tissue Homogenizers, Centrifuges, Cell Culture Plates And Flasks
Pre-Book The Cell Dissociation Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Cell Dissociation Market?
Top firms in the cell dissociation market are prioritizing the development of state-of-the-art products such as cell depletion and enrichment kits to establish a market lead. These kits are engineered for selective depletion or enrichment of specific cell groups, thereby increasing the effectiveness and precision of subsequent applications in both research and clinical environments. For example, LevitasBio, an American biotech company, introduced the LeviSelect Suite of Cell Depletion & Enrichment Kits in February 2023. These kits possess exceptional features such as rapid processing and limited influence on cell survival, improving their relevance in delicate research settings. LeviSelect kits also have adjustable protocols, affording researchers the ability to accurately target an extensive array of cell types.
Who Are the Key Players In The Cell Dissociation Market?
Major companies operating in the cell dissociation market are:
• Roche Holding AG
• Danaher Corporation
• Fujifilm Holdings Corporation
• Becton Dickinson and Company
• GE HealthCare Technologies Inc.
• Corning Incorporated
• Lonza Group AG
• Bio-Rad Laboratories Inc.
• Eppendorf AG
• Bio-Techne Corporation
• Miltenyi Biotec
• BioLegend Inc.
• Cyagen Biosciences Inc.
• Cell Signaling Technology Inc.
• HiMedia Laboratories LLC
• Gemini Bio-Products
• Biological Industries USA Inc.
• BrainBits LLC
• Biocompare Inc.
• AAT Bioquest Inc.
What Are The Regional Insights Into The Cell Dissociation Market?
North America was the largest region in the cell dissociation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell dissociation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
